Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast Cancer
Clinical trial NCT03932526 · UNKNOWN
Trial details
- NCT number
- NCT03932526
- Sponsor
- Liaoning Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-24
- Primary completion
- 2022-12-12
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.